Yale scientists have found that a single dose of psilocybin given to mice induces a rapid and long-lasting increase in connections between pyramidal neurons in the medial frontal cortex, an area of the brain known to be involved in control and decision-making.
Read moreResearch on Psilocybin and DMT
Contemplating a psychedelic “trip”?
Here is all you need to know about two of your options: Psilocybin vs. DMT.
Read morePodcast on Psychedelics
How Psychedelic Drugs Are Making a Comeback to Treat Depression
The hallucinogenic compound psilocybin is undergoing a renaissance-not as a recreational drug but as a potential treatment for mental health conditions. This podcast follows the journey of one participant of a scientific study into the psychedelic drug's effect on depression.
Read moreMushrooms in Space
In a new “astromycological” venture launched in conjunction with NASA, mycologist Paul Stamets and various research teams are studying how fungi can be leveraged to build extraterrestrial habitats and perhaps someday even terraform planets.
Read moreFantastic Fungi on Netflix
The film Fantastic Fungi is now available on Netflix… check it out!
Read moreTest Psilocybin Potency at Home
Want to measure the magic in your mushrooms? The miraculix test kit shows the percentage of psilocybin in your mushrooms.
Read moreHow Mushrooms Started Going Mainstream
In the 1950s, Gordon and Valentina Wasson encountered magic mushrooms. Then they wouldn’t stop talking about them.
Read moreCan a Bad Trip Be a Good Thing?
Psychedelic users say that even bad trips gave them ‘life-altering insights’, a small study finds.
Read moreHow Magic Mushrooms Evolved
Why does nature produce hallucinogenic compounds? One study set out to uncover the answer... keep reading to find out more.
Read morePsilocybin and Terminally Ill Patients
This new study suggests that psilocybin may reduce suicidal thoughts in terminally ill patients.
Read moreInterview: Psilocybin for Depression
In this interview, leading psychedelic researcher, Robin Carhart-Harris, speaks with a participant in a psilocybin for depression trial on the potential of psychedelics.
Read more